AJMC®: Does the prevalence of Demodex blepharitis found by Trattler and colleagues 1 match what you see in clinical practice? BRUJIC: The prevalence of Demodex blepharitis is interesting. Prior to ...

AJMC ®: Can you walk us through your published findings regarding the real-world prevalence of Demodex blepharitis? 1 Why is this an important disease to study? KARPECKI: Demodex blepharitis is one of ...

Impact of Demodex Blepharitis on Patients: Results of the Atlas Trial (ASCRS Paper ID 81946); Mitchell A. Jackson, M.D., et al.

OMAHA, NE - January 22, 2026 - PRESSADVANTAGE - Modern Vision Solutions has announced the publication of a new article, ...

LONDON, Sept. 11, 2023 /PRNewswire/ -- Eyes are one of the vital sense organs of our body that enables us to see everything presence in and around us. It is crucial for us to take care of this gift.

Unique and memorable campaign intended to educate consumers about Demodex blepharitis and XDEMVY, the first and only FDA approved solution for the disease Demodex blepharitis impacts approximately 25 ...

Titan real-world prevalence study data reveals that Demodex blepharitis accounts for over two-thirds of all blepharitis cases and is highly prevalent in many commonly seen patient groups New Titan ...

Patients affected with Demodex Blepharitis may witness diverse symptoms depending on the severity of this ailment. Some of the commonly occurring symptoms are constant tearing, dry eyes, itchiness, ...

Please provide your email address to receive an email when new articles are posted on . Eric D. Donnenfeld, MD: A 39-year-old woman had intractable focal itching of the right lower lid. This is key: ...

Credit: Tarsus Pharmaceuticals. Xdemvy is supplied as an ophthalmic solution containing lotilaner 0.25% (2.5mg/mL) in a 10mL bottle; it is expected to be available by the end of August 2023. The Food ...